MHE Question of the Week: Will the ACA Help Biden and the Democrats?
The 14th anniversary of the Affordable Care Act was this past Saturday.
Some background
President Joe Biden and other Democrats celebrated the 14th anniversary of President Barack Obama signing the Affordable Care Act (ACA) into law on Saturday with a flurry of online posts and images. “14 years later, the Affordable Care Act is still a very big deal,” Biden posted on X, a coy reference to his profane, hot mic version of the same expression at the bill’s signing. Although Biden is running behind Donald Trump in many polls, Biden and the Democrats believe that ACA will be a political asset this fall and could turn the election in their favor. KFF polling shows the law is viewed favorably overall, although approximately two-thirds (67%) of Republicans view it unfavorably and 39% say they want it repealed. Trump has focused on immigration and Biden’s age at his rallies, but in a Truth Social post late last year he said that “the cost of Obamacare is out of control” and that he was seriously looking at alternatives.
Will the Affordable Care Act Help Biden and the Democrats in the November 2024 Election?
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
